CytoDyn raises $4.9M through private placement of 21.3M units at $0.23/unit

CytoDyn Inc.

Proceeds of ~$4.9M from sale of ~21.3M units, each unit one share plus one warrant to purchase one share.
Warrants have 5-year term, exercise price $0.50 per share, exercisable immediately upon issuance.
Placement agent receives 12% cash fee and 10.7M warrants at $0.23 exercise price (10-year term).
Unregistered sales exceeded 5% of outstanding common stock as of Feb 28, 2023; relying on Rule 506 and Section 4(a)(2).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.